A 42-year-old woman with a history of rheumatic heart disease presents to the emergency department with acute dyspnea, orthopnea, and pink frothy sputum. On examination, she is tachycardic (HR 124/min), tachypneic (RR 28/min), and in atrial fibrillation. Auscultation reveals a loud S1, opening snap, and a diastolic murmur. Chest X-ray shows bilateral pulmonary edema and a straightened left heart border. Transthoracic echocardiography shows a mitral valve area of 0.8 cm² and a left atrial thrombus. What is the immediate management priority?

Explanation

## Clinical Presentation **Key Point:** This patient presents with acute decompensated mitral stenosis complicated by atrial fibrillation, pulmonary edema, and LA thrombus. The presence of LA thrombus is an absolute contraindication to percutaneous mitral balloon valvotomy (PMBV) due to risk of systemic embolization. ## Acute Pulmonary Edema in MS The pathophysiology: 1. Mitral stenosis (MVA 0.8 cm²—severe) increases LA pressure 2. Atrial fibrillation (loss of atrial kick) further elevates LA pressure 3. Elevated LA pressure → pulmonary capillary wedge pressure → pulmonary edema 4. Tachycardia shortens diastole → decreased LV filling time → further hemodynamic compromise ## Immediate Management Strategy ```mermaid flowchart TD A[Acute pulmonary edema + MS + LA thrombus]:::urgent --> B[Stabilize acutely]:::action B --> C[IV diuretics, O₂, rate control]:::action B --> D[Anticoagulation]:::action C --> E{Thrombus resolved on repeat imaging?}:::decision D --> E E -->|Yes, after 3-4 weeks| F[PMBV or surgical intervention]:::action E -->|No| G[Consider surgical valve replacement]:::action H[Do NOT perform PMBV with LA thrombus]:::urgent ``` **High-Yield:** LA thrombus is an **absolute contraindication** to PMBV. The mechanical trauma of the balloon can dislodge the thrombus, causing stroke or systemic embolization. Anticoagulation must be initiated and thrombus resolution confirmed (typically 3–4 weeks of therapeutic anticoagulation) before attempting PMBV. ## Immediate Pharmacologic Management | Drug | Indication | Mechanism | |------|-----------|----------| | **IV Furosemide** | Pulmonary edema | Reduces preload, ↓ LA pressure | | **Oxygen** | Hypoxemia | Improves oxygenation | | **Beta-blocker (IV metoprolol)** or **Diltiazem** | AF with RVR | Rate control; improves diastolic filling time | | **Anticoagulation (IV heparin)** | LA thrombus + AF | Prevents thrombus propagation and embolism | | **Digoxin** | Alternative rate control | Positive inotrope; vagomimetic effect | **Clinical Pearl:** In acute MS with AF and pulmonary edema, rate control is critical. Slowing the heart rate increases diastolic filling time, allowing more blood to cross the stenotic mitral valve and reducing LA pressure. ## Why Intervention Must Be Deferred **Mnemonic: THROMBUS — Contraindication to PMBV** - **T**hrombus in LA - **H**eavy calcification - **R**igid, immobile leaflets - **O**verall unfavorable morphology - **M**oderate to severe MR - **B**acterial endocarditis (active) - **U**nstable hemodynamics (relative) - **S**evere subvalvular disease ## Timeline for Intervention 1. **Acute phase (0–48 hours):** Stabilization with diuretics, oxygen, rate control, anticoagulation 2. **Subacute phase (3–4 weeks):** Therapeutic anticoagulation; repeat TEE to confirm thrombus resolution 3. **Definitive phase:** Once thrombus resolved, proceed with PMBV (if favorable anatomy) or surgical replacement (if unfavorable) **Warning:** Attempting PMBV with an LA thrombus is a medical error and significantly increases stroke risk. The balloon catheter can mechanically dislodge the thrombus or cause further thrombosis.